WuXi Biologics Expands Autoimmune and Next-Gen Antibody Exposure through New Partnerships

WuXi Biologics has entered three new alliances with Vertex Pharmaceuticals, Sinorda Biomedicine, and HanchorBio, focusing on antibody therapeutics for autoimmune diseases and advanced bi and multi-functional fusion programs. These partnerships expand WuXi Biologics' role in global biologics research and manufacturing and its work in T cell engager therapies. The collaborations add exposure to autoimmune and next-generation antibody programs, areas many investors closely track in the biologics space.